Loading…
British maker of health, hygiene and nutrition brands including Nurofen, Durex, Lysol/Dettol and Enfamil infant formula.
British maker of health, hygiene and nutrition brands including Nurofen, Durex, Lysol/Dettol and Enfamil infant formula.
Sells branded health, hygiene and baby-formula products in repeat-purchase packs through pharmacies and supermarkets, so brand strength and shelf space drive earnings. Infant formula came with the 2017 purchase of Mead Johnson and sells mostly in North America and Asia. It has sold or spun off several non-core units over the past decade, including a pharmaceuticals arm in 2014 and the Scholl footcare brand.
In one line: UK's Church & Dwight, but larger and more global.
Moat: narrow (brand, distribution). Strong category brands, but faces private-label competition and infant-formula litigation risk.
Headquarters: Slough, UK · Founded: 1999
Size Reckitt Benckiser (RKT.L) is a United Kingdom Consumer Staples company (Household/Personal Care) with a market value of $47.6B, the 21st largest of 363 United Kingdom companies the cockpit tracks. Shares closed at £5,590 on 6 Nov 2026.
Performance Over six months the shares gained 22.2%, against +15.8% for the median peer and +3.6% for the United Kingdom market (cap-weighted) — 5th highest of 16 in its peer set.
Growth Revenue fell 2.5% over the last twelve months (peer median +1.7%); the operating margin is 28.5% (peer median 14.2%).
Valuation It trades at 16.4× forward earnings against a peer median of 24.4× (3rd cheapest of 16).
Price implies For today's price to make sense, revenue must grow about 2% a year for seven years (Req g). Recent delivered growth is 0%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 10.7 points above its cost of capital (8.6% WACC).
Credit Reckitt Benckiser has 11 bonds outstanding ($7.93B), rated A- by the agencies and trading like A at a weighted spread of 85 bp.
Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | £13.6B | £14.2B | £14.2B | £14.6B | £14.5B |
| Revenue growth | — | 0% | -3% | +1% | — |
| Gross profit | £8.11B | £8.49B | £8.57B | £8.73B | £8.33B |
| EBITDA | £4.80B | £3.92B | £3.92B | £3.79B | £3.97B |
| Net income | £2.88B | £3.18B | £1.43B | £1.63B | £2.34B |
| Free cash flow | £1.55B | £1.76B | £2.31B | £2.29B | £2.04B |
| Capital expenditure | £616M | £615M | £465M | £449M | £443M |
| Total debt | n/a | £8.43B | £8.66B | £8.54B | £8.88B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Reckitt Benckiser RKT.L | $47.6B | +22% | -2% | 28% | 16.4× | 1.6% |
| Procter & Gamble PG | $383B | +13% | +4% | 24% | 23.4× | -0.3% |
| Unilever ULVR.L | $143B | +15% | -20% | 20% | 18.4× | 8.0% |
| Haleon HLN.L | $40.1B | +1% | +1% | 23% | 16.3× | 4.6% |
| Church & Dwight CHD | $25.8B | +17% | +2% | 18% | 27.4× | 6.9% |
| Colgate-Palmolive CL | $76.8B | +10% | +6% | 22% | 24.2× | -5.5% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | RKT.L | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +10.2% | +10.9% | 7th lowest of 16 |
| 6-month return | +22.2% | +15.8% | 5th highest of 16 |
| Distance from 52-week high | -14.2% | -5.1% | 4th lowest of 16 |
| Revenue growth (TTM) | -2.5% | +1.7% | 5th lowest of 16 |
| Operating margin | 28.5% | 14.2% | highest of 16 |
| Forward P/E | 16.4× | 24.4× | 3rd cheapest of 16 |
| Growth the price implies (Req g, 7 yrs) | 1.6% | 4.1% | 7th least demanding of 16 |
| Growth delivered (Del g) | +0.3% | +4.1% | 5th lowest of 16 |
| Hurdle (Req g minus delivered) | +1.3 pp | +4.4 pp | 7th least demanding of 16 |
| ROIC minus cost of capital | +10.7 pp | +6.6 pp | 5th highest of 16 |
| EV / EBITDA | 9.3× | 15.8× | cheapest of 16 |
| Net debt / EBITDA | 1.9× | 1.4× | 6th most indebted of 16 |
| Bond spread | 85 bp | 67 bp | widest of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Reckitt Benckiser RKT.L | United Kingdom | $47.6B | +22% | -2% | 28% | 16.4× | 1.6% | +0.3% |
| Givaudan GIVN.SW | Switzerland | $45.8B | +47% | -2% | 18% | 34.0× | 10.6% | +3.4% |
| Hindustan Unilever HINDUNILVR.NS | India | $49.6B | -12% | +6% | 21% | 41.5× | 27.2% | +6.5% |
| Estée Lauder Companies (The) EL | United States | $39.9B | +28% | +6% | 13% | 31.1× | 16.8% | -1.5% |
| Kimberly-Clark KMB | United States | $66.5B | +12% | -12% | 14% | 15.3× | 4.1% | -3.0% |
| Colgate-Palmolive CL | United States | $76.8B | +10% | +6% | 22% | 24.2× | -5.5% | +4.4% |
| DSM-Firmenich DSFIR.AS | Netherlands | $29.5B | +62% | -45% | 8% | 30.1× | 24.3% | +2.5% |
| Church & Dwight CHD | United States | $25.8B | +17% | +2% | 18% | 27.4× | 6.9% | +4.8% |
| Kao 4452.T | Japan | $21.8B | +33% | +6% | 10% | 24.4× | 1.5% | +4.1% |
| Beiersdorf BEI.DE | Germany | $20.4B | +21% | -2% | 12% | 22.6× | -2.3% | +7.0% |
| Essity ESSITY-A.ST | Sweden | $19.9B | +17% | -2% | 12% | 15.4× | -3.3% | +2.6% |
| Unilever ULVR.L | United Kingdom | $143B | +15% | -20% | 20% | 18.4× | 8.0% | -0.8% |
| Puig Brands PUIG.MC | Spain | $12.5B | +16% | +4% | 16% | 17.9× | -3.0% | +11.7% |
| Marico MARICO.NS | India | $12.3B | +8% | +20% | 16% | 51.8× | 28.0% | +11.1% |
| Unicharm 8113.T | Japan | $12.1B | +15% | 0% | 12% | 24.5× | -2.0% | +5.4% |
| Clorox CLX | United States | $12.1B | +8% | +6% | 14% | 17.4× | 2.7% | -1.8% |
Reckitt Benckiser has 11 bonds outstanding with $7.93B face value. The agencies rate it A-; its bonds trade like A. Weighted yield 4.24%, a spread of 85 bp over government bonds.